Sculptor Capital LP - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 140 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2019$50,000
+8.7%
10,6000.0%0.00%
Q3 2019$46,000
-94.9%
10,600
-93.2%
0.00%
-100.0%
Q2 2019$906,000
-54.0%
155,400
-69.6%
0.00%
-83.3%
Q1 2019$1,970,000
+139.7%
511,600
+16.4%
0.01%
+100.0%
Q4 2018$822,000
-23.6%
439,600
+159.2%
0.01%0.0%
Q1 2017$1,076,000
+75.8%
169,600
+48.3%
0.01%
+50.0%
Q4 2016$612,000
-5.0%
114,4000.0%0.00%0.0%
Q3 2016$644,000114,4000.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$49,697,00012.67%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 9,642,760$31,628,0005.74%
MILLER VALUE PARTNERS, LLC 12,619,730$41,393,0001.84%
MAGNOLIA CAPITAL ADVISORS LLC 90,585$297,0000.38%
Sargent Investment Group, LLC 232,025$759,0000.28%
Old West Investment Management, LLC 210,583$690,0000.20%
Virtus ETF Advisers LLC 112,619$369,0000.18%
tru Independence LLC 213,712$701,0000.10%
Golden State Wealth Management, LLC 90,585$297,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 180,297$591,0000.08%
View complete list of ZIOPHARM ONCOLOGY INC shareholders